PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-2001

  1. 832 Posts.
    lightbulb Created with Sketch. 331
    Get IPPS through FDA / TGA is the answer.

    It's bull#hit the amount of time its taken for IPPS to get approval given the unmet need and the programs that they have had running. If you look back at some of the studies (and Im talking pre 2000) the evidence is clear. Yet hear we are 2021 taking about a 2024-25 registration.... No major AE's, great safety record and it works....

    After the last PAR update their references to Aus / Europe has me thinking they are abandoning the "global" registration and looking to push AU / EU as US may take a little longer than PR first thought (IMO). The FDA seem content to stall because they can...
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.